| Complement C 1q‐C 3–associated synaptic changes in multiple sclerosis hippocampus I Michailidou, JGP Willems, EJ Kooi, C van Eden, SM Gold, JJG Geurts, ... Annals of neurology 77 (6), 1007-1026, 2015 | 210 | 2015 |
| Complement is activated in progressive multiple sclerosis cortical grey matter lesions LM Watkins, JW Neal, S Loveless, I Michailidou, V Ramaglia, MI Rees, ... Journal of neuroinflammation 13, 1-13, 2016 | 118 | 2016 |
| Cellular distribution of glucose and monocarboxylate transporters in human brain white matter and multiple sclerosis lesions PG Nijland, I Michailidou, ME Witte, MR Mizee, SMA van der Pol, ... Glia 62 (7), 1125-1141, 2014 | 114 | 2014 |
| Meningeal inflammation in multiple sclerosis induces phenotypic changes in cortical microglia that differentially associate with neurodegeneration L van Olst, C Rodriguez-Mogeda, C Picon, S Kiljan, RE James, ... Acta Neuropathologica 141, 881-899, 2021 | 65 | 2021 |
| Complement C3 on microglial clusters in multiple sclerosis occur in chronic but not acute disease: Implication for disease pathogenesis I Michailidou, DMP Naessens, S Hametner, W Guldenaar, EJ Kooi, ... Glia 65 (2), 264-277, 2017 | 61 | 2017 |
| Systemic inhibition of the membrane attack complex impedes neuroinflammation in chronic relapsing experimental autoimmune encephalomyelitis I Michailidou, A Jongejan, JP Vreijling, T Georgakopoulou, MB de Wissel, ... Acta neuropathologica communications 6, 1-17, 2018 | 53 | 2018 |
| Phenotypic variation in Aicardi–Goutières syndrome explained by cell-specific IFN-stimulated gene response and cytokine release E Cuadrado, I Michailidou, EJ Van Bodegraven, MH Jansen, JA Sluijs, ... The journal of immunology 194 (8), 3623-3633, 2015 | 51 | 2015 |
| Activation of endogenous neural stem cells for multiple sclerosis therapy I Michailidou, HE de Vries, EM Hol, ME van Strien Frontiers in neuroscience 8, 454, 2015 | 34 | 2015 |
| Accumulation of meningeal lymphocytes correlates with white matter lesion activity in progressive multiple sclerosis SM Ahmed, NL Fransen, H Touil, I Michailidou, I Huitinga, ... JCI insight 7 (5), 2022 | 32 | 2022 |
| Tackling neuroinflammation after traumatic brain injury: Complement inhibition as a therapy for secondary injury IAM van Erp, I Michailidou, TA van Essen, M van der Jagt, W Moojen, ... Neurotherapeutics 20 (1), 284-303, 2023 | 21 | 2023 |
| Balloon cells promote immune system activation in focal cortical dysplasia type 2b TS Zimmer, DWM Broekaart, M Luinenburg, C Mijnsbergen, JJ Anink, ... Neuropathology and applied neurobiology 47 (6), 826-839, 2021 | 21 | 2021 |
| Development, characterization, and in vivo validation of a humanized C6 monoclonal antibody that inhibits the membrane attack complex H Gytz Olesen, I Michailidou, WM Zelek, J Vreijling, P Ruizendaal, ... Journal of innate immunity 15 (1), 16-36, 2023 | 3 | 2023 |
| The systemic inhibition of the terminal complement system reduces neuroinflammation but does not improve motor function in mouse models of CMT1A with overexpressed PMP22 I Michailidou, J Vreijling, M Rumpf, M Loos, B Koopmans, N Vlek, N Straat, ... Current Research in Neurobiology 4, 100077, 2023 | 3 | 2023 |
| Sex, aging and immunity in multiple sclerosis and experimental autoimmune encephalomyelitis: An intriguing interaction M Boziki, P Theotokis, E Kesidou, E Karafoulidou, C Konstantinou, ... Frontiers in Neurology 13, 1104552, 2023 | 2 | 2023 |
| Accumulation of meningeal lymphocytes, but not myeloid cells, correlates with subpial cortical demyelination and white matter lesion activity in progressive MS patients SM Ahmed, N Fransen, H Touil, I Michailidou, I Huitinga, JL Gommerman, ... MedRxiv, 2021.12. 20.21268104, 2021 | 2 | 2021 |
| PMP22 duplication dysregulates lipid homeostasis and plasma membrane organization in developing human Schwann cells R Prior, A Silva, T Vangansewinkel, J Idkowiak, AK Tharkeshwar, ... Brain, awae158, 2024 | 1 | 2024 |
| Complement in nervous system disease I Michailidou, K Fluiter, M Boziki, N Grigoriadis, F Baas Frontiers in cellular neuroscience 17, 1268023, 2023 | 1 | 2023 |
| Defective Schwann cell lipid metabolism alters plasma membrane dynamics in Charcot-Marie-Tooth disease 1A R Prior, A Silva, T Vangansewinkel, J Idkowiak, AK Tharkeshwar, ... bioRxiv, 2023.04. 02.535224, 2023 | 1 | 2023 |
| Neurological Immune-Related Adverse Events Induced by Immune Checkpoint Inhibitors S Stavropoulou De Lorenzo, A Andravizou, H Alexopoulos, I Michailidou, ... Biomedicines 12 (6), 1319, 2024 | | 2024 |
| Systemic LPS Administration Stimulates the Activation of Non-Neuronal Cells in an Experimental Model of Spinal Muscular Atrophy E Karafoulidou, E Kesidou, P Theotokis, C Konstantinou, MK Nella, ... Cells 13 (9), 785, 2024 | | 2024 |
